In this study, we developed a FGF21-related PHS to explore the genetic contribution of the FGF21 pathway to NAFLD incidence and sought to ascertain whether the association between the PHS and NAFLD risk is modulated by dietary protein intake level. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.